A Longitudinal Observational Study of the Natural History and Management of Patients With HCC (NCT02954094)
🩺 Plain-English Summary (8th-Grade Level)
TARGET-HCC is a longitudinal, observational study of patients being managed for HCC in usual clinical practice. TARGET-HCC will create a research registry of participants with HCC within academic and community real-world practices in order to assess the safety and effectiveness of the entire spectrum of current and future therapies across diverse populations.
Who can join: To join this study, participants generally need to meet the listed inclusion criteria (2 items) and avoid the listed exclusions (1 items).
Location: Banner University Medical Center — Phoenix, Arizona
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistCheck every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).
Usually NOT eligible if any of the following apply:
- Exclusion Criteria: 1\. Inability to provide written informed consent
🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.
📍 All Participating Trial Locations (71 Sites)
- Banner University Medical Center — Phoenix, Arizona
- University of Arkansas — Little Rock, Arkansas
- University of Southern California/Norris Comprehensive Cancer Center — Los Angeles, California
- Stanford University — Palo Alto, California
- California Liver Research Institute — Pasadena, California
- University of California-Davis — Sacramento, California
- University of California — San Francisco, California
- Georgetown University — Washington D.C., District of Columbia
- Gastro Florida — Clearwater, Florida
- University of Florida Hepatology Research at CTRB — Gainesville, Florida
- University of Florida Health Gastroenterology — Jacksonville, Florida
- Schiff Center for Liver Diseases/University of Miami — Miami, Florida
- Tampa General Medical Group — Tampa, Florida
- Piedmont Atlanta Hospital — Atlanta, Georgia
- Piedmont Cancer Institute — Atlanta, Georgia
- Emory University Hospital — Atlanta, Georgia
- Northwestern University Division of Gastroenterology and Hepatology — Chicago, Illinois
- Rush University Medical Center — Chicago, Illinois
- University of Chicago — Chicago, Illinois
- University of Iowa Hospitals and Clinics — Iowa City, Iowa
- Tulane University — New Orleans, Louisiana
- Mercy Medical Center, GI Research — Baltimore, Maryland
- Johns Hopkins University — Baltimore, Maryland
- Beth Israel Deaconess Medical Center — Boston, Massachusetts
- University of Michigan — Ann Arbor, Michigan
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.